You are here

Xylitol pediatric topical oral syrup to prevent dental caries: a double-blind randomized clinical trial of efficacy.

TitleXylitol pediatric topical oral syrup to prevent dental caries: a double-blind randomized clinical trial of efficacy.
Publication TypeJournal Article
Year of Publication2009
AuthorsMilgrom, P, Ly, KA, Tut, OK, Mancl, L, Roberts, MC, Briand, K, Gancio, MJane
JournalArch Pediatr Adolesc Med
Volume163
Issue7
Pagination601-7
Date Published2009 Jul
ISSN1538-3628
KeywordsAdministration, Oral, Dental Caries, DMF Index, Dosage Forms, Double-Blind Method, Female, Humans, Incidence, Infant, Male, Micronesia, Otitis Media, Poisson Distribution, Sorbitol, Treatment Outcome, Xylitol
Abstract

OBJECTIVES: To evaluate the effectiveness of a xylitol pediatric topical oral syrup to reduce the incidence of dental caries among very young children and to evaluate the effect of xylitol in reducing acute otitis media in a subsequent study.

DESIGN: Double-blind randomized controlled trial.

SETTING: Communities in the Republic of the Marshall Islands.

PARTICIPANTS: One hundred eight children aged 9 to 15 months were screened, and 100 were enrolled. Intervention Children were randomized to receive xylitol topical oral syrup (administered by their parents) twice a day (2 xylitol [4.00-g] doses and 1 sorbitol dose) (Xyl-2 x group) or thrice per day (3 xylitol [2.67-g] doses) (Xyl-3x group) vs a control syrup (1 xylitol [2.67-g] dose and 2 sorbitol doses) (control group).

MAIN OUTCOME MEASURES: The primary outcome end point of the study was the number of decayed primary teeth. A secondary outcome end point was the incidence of acute otitis media for reporting in a subsequent report.

RESULTS: Ninety-four children (mean [SD] age, 15.0 [2.7] months at randomization) with at least 1 follow-up examination were included in the intent-to-treat analysis. The mean (SD) follow-up period was 10.5 (2.2) months. Fifteen of 29 of the children in the control group (51.7%) had tooth decay compared with 13 of 32 children in the Xyl-3x group (40.6%) and eight of 33 children in the Xyl-2x group (24.2%). The mean (SD) numbers of decayed teeth were 1.9 (2.4) in the control group, 1.0 (1.4) in the Xyl-3x group, and 0.6 (1.1) in the Xyl-2x group. Compared with the control group, there were significantly fewer decayed teeth in the Xyl-2x group (relative risk, 0.30; 95% confidence interval, 0.13-0.66; P = .003) and in the Xyl-3x group (0.50; 0.26-0.96; P = .04). No statistical difference was noted between the 2 xylitol treatment groups (P = .22).

CONCLUSION: Xylitol oral syrup administered topically 2 or 3 times daily at a total daily dose of 8 g was effective in preventing early childhood caries.

DOI10.1001/archpediatrics.2009.77
Alternate JournalArch Pediatr Adolesc Med
PubMed ID19581542
PubMed Central IDPMC2722805
Grant ListR40 MC03622 / / PHS HHS / United States
U54 DE014254 / DE / NIDCR NIH HHS / United States
U54 DE014254-07 / DE / NIDCR NIH HHS / United States
U54 DE14254 / DE / NIDCR NIH HHS / United States